Status:

UNKNOWN

Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)

Lead Sponsor:

Ospedale San Raffaele

Conditions:

Hypertension

Eligibility:

All Genders

25-60 years

Phase:

PHASE3

Brief Summary

This is a pharmacogenomic prospective , four-arms, parallel groups, active comparator controlled study in essential hypertensive patients never treated before. Each patient will be genotyped for SNPs...

Detailed Description

At screening visit each patient will be genotyped for SNPs in preliminary genetic profiles with a custom SNP array. The therapy scheme includes 2-4-week run-in period after which eligible patients wi...

Eligibility Criteria

Inclusion

  • Male/Female patients aged 25-60 years.
  • Naive hypertensive patients (newly diagnosed, never treated before).
  • Documented mild to moderate arterial hypertension, as defined below:
  • At Visits 1 and 2 (week -4 and week -2 run-in period) the mean of the last 3 consecutive readings of office SBP must be \>= 140 mmHg and/or DBP must be \>=90 mmHg, when measured by office blood pressure (OBP);
  • At Visit 3 (week 0) enrolment , the mean of the last 3 consecutive readings of SBP must be \>= 140 mmHg and \<160 mmHg, and DBP must be \>= 90 mmHg and \<110 mmHg, when measured by OBP.
  • Signed informed consent for genotyping.

Exclusion

  • known causes of secondary hypertension;
  • pregnant, nursing women or women of childbearing potential taking anti-contraceptive medication;
  • severe or malignant hypertension;
  • history of renal artery disease;
  • significant renal disease (estimated creatinine clearance less than 60 mL/min);
  • hepatic disease;
  • cardiac diseases (myocardial infarction, atrial fibrillation, etc);
  • diabetes (fasting plasma glucose \>125mg/dL);
  • statin treatment;
  • obesity (BMI\>30 kg/m2).

Key Trial Info

Start Date :

March 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2018

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT03249285

Start Date

March 1 2016

End Date

November 1 2018

Last Update

August 15 2017

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Azienda Sanitaria 6

Livorno, Italy, 57121

2

San Raffaele Hospital

Milan, Italy, 20131

3

Azienda Ospedaliero - Universitaria S. Maria della Misericordia

Udine, Italy, 33170

Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) | DecenTrialz